menu
    • menu

    Company profile for Actinium pharmaceuticals

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Actinium Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing targeted therapies for potentially superior myeloablation and conditioning of the bone marrow prior to a bone marrow transplant and for the targeting and killing of cancer cells. Our targeted therapies have demonstrated the potential to result in significantly improved access to bone marrow transplant with bet...
    Actinium Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing targeted therapies for potentially superior myeloablation and conditioning of the bone marrow prior to a bone marrow transplant and for the targeting and killing of cancer cells. Our targeted therapies have demonstrated the potential to result in significantly improved access to bone marrow transplant with better outcomes, namely increased marrow engraftment and survival.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Actinium pharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    275 Madison Avenue, 7th Floor New York, NY 10016
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.actiniumpharma.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/actinium-pharmaceuticals-inc-
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/actiniumpharma?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Actinium Pharma Shows ATNM-400's Strong Anti-Tumor Activity
    Actinium Pharma Shows ATNM-400's Strong Anti-Tumor Activity

    12 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/actinium-pharmaceuticals-presents-new-preclinical-data-demonstrating-potent-anti-tumor-activity-of-atnm-400-across-multiple-breast-cancer-subtypes-including-hormone-receptor-positive-triple-negative-and-tamoxifen--and-her2-thera-302640194.html

    PR NEWSWIRE
    12 Dec 2025
    Share Share
    Actinium Reveals ATNM-400's Strong Efficacy in Breast Cancer
    Actinium Reveals ATNM-400's Strong Efficacy in Breast Cancer

    01 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/actinium-pharmaceuticals-announces-atnm-400-data-demonstrating-potent-efficacy-in-triple-negative-breast-cancer-and-ability-to-overcome-endocrine-and-her2-targeted-therapy-resistance-being-presented-at-the-san-antonio-breast-cance-302629128.html

    PR NEWSWIRE
    01 Dec 2025
    Share Share
    Actinium Pharma To Present ATNM-400 Data In Breast Cancer
    Actinium Pharma To Present ATNM-400 Data In Breast Cancer

    04 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/actinium-pharmaceuticals-inc-to-highlight-atnm-400-data-in-hormone-resistant-and-her2-resistant-breast-cancer-at-the-2025-san-antonio-breast-cancer-symposium-expanding-pan-tumor-profile-across-three-solid-tumor-indications-302603350.html

    PR NEWSWIRE
    04 Nov 2025
    Share Share
    Actinium Pharma Joins Stephens Biotech Virtual Fireside Chat
    Actinium Pharma Joins Stephens Biotech Virtual Fireside Chat

    03 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/actinium-pharmaceuticals-inc-to-participate-in-the-stephens-biotechnology-virtual-fireside-chat-conference-302602470.html

    PR NEWSWIRE
    03 Nov 2025
    Share Share
    Actinium Announces Superior Anti-Tumor Activity of ATNM-400
    Actinium Announces Superior Anti-Tumor Activity of ATNM-400

    27 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/actinium-announces-superior-anti-tumor-activity-of-atnm-400-in-lung-cancer-compared-to-the-leading-first-second-and-third-line-approved-egfr-mutant-therapies-and-mechanistic-synergy-with-osimertinib-at-the-aacr-nci-eortc-internat-302595195.html

    PR NEWSWIRE
    27 Oct 2025
    Share Share
    Actinium Pharma Shows Strong ATNM-400, Efficacy In Multi-Tumor
    Actinium Pharma Shows Strong ATNM-400, Efficacy In Multi-Tumor

    24 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/actinium-pharmaceuticals-presents-new-data-demonstrating-potent-and-durable-efficacy-of-atnm-400-a-first-in-class-multi-tumor-actinium-225-radiotherapy-at-the-32nd-annual-prostate-cancer-foundation-scientific-retreat-302593853.html

    PR NEWSWIRE
    24 Oct 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search